BOT 3.17% 32.5¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-168

  1. 324 Posts.
    lightbulb Created with Sketch. 91
    Folks, the stock is essentially underwritten here.

    cash in bank
    potential for Ph 3 Acne
    1801 met primary end points

    this is getting re-rated.

    profit taking is expected and I hope it cleans up the register.

    I genuinely think it’s cheap here and once some profit taking is concluded, it grinds higher. It’s probably a buying opp for those looking to top up.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.5¢
Change
0.010(3.17%)
Mkt cap ! $583.7M
Open High Low Value Volume
31.0¢ 33.5¢ 30.5¢ $4.513M 14.27M

Buyers (Bids)

No. Vol. Price($)
14 299858 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 208818 10
View Market Depth
Last trade - 15.47pm 02/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.